Keyphrases
Periprosthetic Joint Infection
100%
Single-center Study
42%
1-year Follow-up
42%
High-volume Center
42%
Diabetic Foot
30%
Total Hip Arthroplasty
28%
Antibiotics
23%
One-stage Revision
22%
Revision Total Knee Arthroplasty
20%
Debridement
19%
Bacteremia
17%
Total Knee Arthroplasty
17%
Knee
16%
Primary Knee Replacement
16%
Primary Hip Replacement
16%
Oral Antibiotics
16%
Confidence Interval
15%
Soft Tissue Flaps
14%
Cellulitis
14%
New Criteria
14%
Antibiotic Use
14%
Patient-reported Outcomes
14%
Comorbidity
14%
Clinical Outcomes
14%
Cephalosporin Antibiotics
14%
Superficial Cultures
14%
Antibiotic Prophylaxis
14%
Major Amputation
14%
Probiotic Supplement
14%
Fungemia
14%
Saccharomyces Boulardii
14%
Arthroplasty
14%
Fungal Infection
14%
Flap Reconstruction
14%
Knee Joint
14%
Total Joint Replacement Surgery
14%
Serofast
14%
Mycoplasma Pneumoniae (M. pneumoniae)
14%
Serological Methods
14%
Staphylococcus Aureus
13%
Diagnostic Criteria
12%
Saccharomyces
11%
Complement Fixation Test
11%
Implant Retention
11%
Two-stage Revision
10%
Enzyme-linked Immunosorbent Assay (ELISA)
9%
Comorbidity Burden
8%
Primary THA
8%
Reoperation
8%
International Consensus Meeting
8%
Medicine and Dentistry
Infection
33%
Periprosthetic Joint Infection
28%
Antibiotics
25%
Amputation
20%
Bloodstream Infection
16%
Retrospective Study
15%
Hip Replacement
15%
Knee Replacement
15%
Implant
14%
Debridement
14%
Infectious Arthritis
14%
Revision Hip Arthroplasty
14%
Reoperation
14%
Knee Joint
14%
Arthroplasty
14%
One-Stage Revision
14%
Fungemia
14%
Hazard Ratio
14%
Mycosis
14%
Total Knee Arthroplasty
14%
Prosthetics
14%
Mycoplasma Pneumonia
14%
Complement Fixation Test
14%
Patient-Reported Outcome
14%
Soft Tissue Flap Reconstruction
14%
Probiotics
14%
Enzyme Immunoassay
12%
Diabetes Mellitus
10%
Joint Replacement
9%
Overall Survival
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
55%
Periprosthetic Joint Infection
42%
Infectious Arthritis
42%
Antibiotics
29%
Comorbidity
23%
Retrospective Study
18%
Infectious Agent
18%
Bloodstream Infection
17%
Implant
14%
Cephalosporin
14%
Antibiotic Prophylaxis
14%
Mycosis
14%
Saccharomyces Boulardii
14%
Fungemia
14%
Budding Yeast
14%
Staphylococcus Aureus
13%
Diabetes Mellitus
12%
Overall Survival
7%
Diseases
7%
Gram Negative Bacterium
5%
Ischemia
5%
Wound
5%
